Spearhead Capital Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,448
| Closed | -$298K | – | 145 |
|
|
2022
Q2 | $298K | Sell |
7,448
-105
| -1% | -$4.2K | 0.04% | 128 |
|
|
2022
Q1 | $282K | Sell |
7,553
-513
| -6% | -$19.2K | 0.03% | 145 |
|
|
2021
Q4 | $321K | Buy |
8,066
+140
| +2% | +$5.57K | 0.04% | 141 |
|
|
2021
Q3 | $295K | Sell |
7,926
-36
| -0.5% | -$1.34K | 0.04% | 155 |
|
|
2021
Q2 | $337K | Buy |
7,962
+1,463
| +23% | +$61.9K | 0.05% | 168 |
|
|
2021
Q1 | $308K | Buy |
+6,499
| New | +$308K | 0.05% | 164 |
|